Timing Effect of Ultrasound-Guided PVB After Robotic Cardiac Surgery
Randomized, Single-Blinded Study to Evaluate the Timing Effect of Ultrasound-Guided Paravertebral Block in Patients Undergoing Robotic Mitral Valve Repair Procedure
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
This study is to evaluate whether the administration of ultrasound-guided paravertebral block (PVB) after surgery would produce better postoperative pain control and fast postoperative recovery after Robotic cardiac surgery. Half of participants will receive PVB before surgery, while the other half will receive PVB at the end of surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2020
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 25, 2020
CompletedFirst Posted
Study publicly available on registry
March 6, 2020
CompletedStudy Start
First participant enrolled
September 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2021
CompletedJuly 24, 2020
July 1, 2020
6 months
February 25, 2020
July 23, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Durations of ICU and hospitalization
Duration (days) of ICU stay, and duration of hospital stay
2-6 days
Secondary Outcomes (1)
Pain intensity measure
2-3 days
Study Arms (2)
PVB before surgery
ACTIVE COMPARATORPVB after surgery
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Age ≥ 18 yrs
- ASA I-IV
- Either gender
You may not qualify if:
- Refusal to participate in the study
- Age\< 18 yrs
- Contraindications to regional blockage including but not limited to:
- Patient refusal to regional blockade
- Infection at the site of needle insertion
- Systemic infection
- Bleeding diathesis or coagulopathy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcomes assessor will be blinded to study group
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 25, 2020
First Posted
March 6, 2020
Study Start
September 1, 2020
Primary Completion
February 28, 2021
Study Completion
March 31, 2021
Last Updated
July 24, 2020
Record last verified: 2020-07
Data Sharing
- IPD Sharing
- Will not share